Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Sow
    Member
    • Feb 2016
    • 16

    #1

    RNASeq pipeline

    Hi,

    I was wanting to know if it is alright to normalize my RNA seq data before mapping the reads to the genome? I ask this because I have the raw file, however the mapping was performed by a bioinformatician who did not provide us the mapped reads file but just the output from after running all the pipelines.

    Also, can I run a differential gene expression analysis on the raw reads - even before mapping? Would these results be accepted as valid fold changes if performed on the original files?

    Thank you
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Originally posted by Sow View Post
    Hi,

    I was wanting to know if it is alright to normalize my RNA seq data before mapping the reads to the genome?
    No.

    I ask this because I have the raw file, however the mapping was performed by a bioinformatician who did not provide us the mapped reads file but just the output from after running all the pipelines.
    He should provide you the mapped reads upon request.

    Also, can I run a differential gene expression analysis on the raw reads - even before mapping?
    No, that's impossible. How can you know which read goes to which gene without mapping? That's the definition of mapping.

    Comment

    • Sow
      Member
      • Feb 2016
      • 16

      #3
      Thanks so much Brain,
      I should have mentioned that this is an small RNA Seq data. So mapping tells us if the reads come from the genome or if it's a random degraded transcript. However it is right not to run differential expression analysis on the raw reads - isn't that what deseq requires us to do?
      Also- I was hoping I could obtain the fold change of the miRNAs ( obtained after running the pipeline) from the differential expression Analysis of the raw reads?

      Comment

      • ddb
        Member
        • Feb 2012
        • 13

        #4
        Note that raw reads and raw read counts (what DESeq requires) have a different meaning. Raw reads suggests your data as it came from the sequencer. Raw read counts is the number of reads that map to the genes / features of interest without normalization for factors like library size. You cannot get raw read counts without mapping first.

        Comment

        • WhatsOEver
          Senior Member
          • Apr 2012
          • 215

          #5
          Originally posted by Brian Bushnell View Post
          No, that's impossible. How can you know which read goes to which gene without mapping? That's the definition of mapping.
          Not completely true. K-mer counting based tools like "salmon" or "kallisto" can perform differential gene expression analysis without the "classical" mapping. But you'll need to have well curated transcriptome sequences and identification of novel transcripts or isoforms is obviously also not possible.
          Nevertheless, the tools work with "raw reads" as the op requested

          Comment

          • Brian Bushnell
            Super Moderator
            • Jan 2014
            • 2709

            #6
            Originally posted by WhatsOEver View Post
            Not completely true. K-mer counting based tools like "salmon" or "kallisto" can perform differential gene expression analysis without the "classical" mapping.
            Or Seal

            But I would argue that what those tools do is mapping, just without an alignment phase.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 10:52 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            16 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...